Body substance isolation

Last updated

Body substance isolation (BSI) is a practice of isolating all body substances (blood, urine, feces, tears, etc.) of individuals undergoing medical treatment, particularly emergency medical treatment of those who might be infected with illnesses such as HIV or hepatitis so as to reduce as much as possible the chances of transmitting these illnesses. [1] This technique was first implemented at Harborview Medical Center in Seattle, Washington. [2] BSI is similar in nature to universal precautions, but goes further in isolating workers from pathogens, including substances now known to carry HIV. [3]

Contents

Place of body substance isolation practice in history

Universal precautions were introduced by the Center for Disease Control and Prevention in 1985 in response to the HIV epidemic. [4] [5] In 1987, these guidelines were adjusted by a set of rules known as body substance isolation. In 1996, core elements of both universal precautions and BSI were integrated into a practice known as standard precautions. [6]

BSI went further than universal precautions in isolating workers from pathogens, including substances now currently known to carry HIV. These pathogens fall into two broad categories, blood-borne (carried in the body fluids) and airborne. The practice of BSI was common in pre-hospital care and emergency medical services due to the often unknown nature of the patient and their disease or medical conditions. It was a part of the National Standards Curriculum for Prehospital Providers and Firefighters. Types of body substance isolation included:[ citation needed ]

It was postulated that BSI precautions should be practiced in an environment where treaters were exposed to bodily fluids, such as:

Such infection control techniques that were recommended following the AIDS outbreak in the 1980s. Every patient was treated as if infected, and therefore precautions were taken to minimize risk. Other conditions which called for minimizing risks with BSI:

or any combination of the above.


See also

Footnotes

  1. 1 2 LYNCH, PATRICIA; Jackson, M. M.; Cummings, M. J.; Stamm, W. E. (1 August 1987). "Rethinking the Role of Isolation Practices in the Prevention of Nosocomial Infections". Annals of Internal Medicine. 107 (2): 243–6. doi:10.7326/0003-4819-107-2-243. PMID   3605901.
  2. Lynch, P.; Cummings, M. J.; Roberts, P. L.; Herriott, M. J.; Yates, B.; Stamm, W. E. (February 1990). "Implementing and evaluating a system of generic infection precautions: body substance isolation". American Journal of Infection Control. 18 (1): 1–12. doi:10.1016/0196-6553(90)90204-6. ISSN   0196-6553. PMID   2156467.
  3. Kopitnik, Nancy L.; Kahwaji, Chadi I. (2025), "Universal Precautions", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29262198 , retrieved 2025-12-23
  4. "Leads from the MMWR. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings". JAMA: The Journal of the American Medical Association. 260 (4): 462–465. 1988. doi:10.1001/jama.260.4.462.
  5. Kopitnik, Nancy L.; Kahwaji, Chadi I. (2025), "Universal Precautions", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29262198 , retrieved 2025-12-23
  6. Kopitnik, Nancy L.; Kahwaji, Chadi I. (2025), "Universal Precautions", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29262198 , retrieved 2025-12-23

Further reading